11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Endocrine reviews

• Publication date

  2013-04-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/er.2012-1050PMID 23612224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal Elevation of β-Cell 11β-Hydroxysteroid Dehydrogenase Type 1 Is a Compensatory Mechanism That Prevents High-Fat Diet–Induced β-Cell Failure

  2012cited by this paper
• Biomarkers of hypothalamic–pituitary–adrenal axis activity in mice lacking 11β-HSD1 and H6PDH

  2012cited by this paper
• The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.

  2012cited by this paper
• The effect of common genetic variation in 11β-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression.

  2012cited by this paper
• Salicylate Downregulates 11β-HSD1 Expression in Adipose Tissue in Obese Mice and in Humans, Mediating Insulin Sensitization

  2012cited by this paper
• Liver Upregulation of Genes Involved in Cortisol Production and Action Is Associated with Metabolic Syndrome in Morbidly Obese Patients

  2012cited by this paper
• Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling

  2012cited by this paper
• 11β-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease.

  2012cited by this paper
• Lack of Significant Metabolic Abnormalities in Mice with Liver-Specific Disruption of 11β-Hydroxysteroid Dehydrogenase Type 1

  2012cited by this paper
• Association between 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population

  2012cited by this paper
• BVT.2733, a Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Attenuates Obesity and Inflammation in Diet-Induced Obese Mice

  2012cited by this paper
• A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease

  2012cited by this paper
• Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage.

  2012cited by this paper
• A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children

  2012cited by this paper
• A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome.

  2011cited by this paper
• Identification of cyclicsulfonamide derivatives with an acetamide group as 11β-hydroxysteroid dehydrogenase 1 inhibitors.

  2011cited by this paper
• Clinical practice. Glucocorticoid-induced bone disease.

  2011cited by this paper
• Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.

  2011cited by this paper
• Can 11β-Hydroxysteroid Dehydrogenase Activity Predict the Sensitivity of Bone to Therapeutic Glucocorticoids in Inflammatory Bowel Disease?

  2011cited by this paper
• Synthesis of potent and orally efficacious 11β-hydroxysteroid dehydrogenase type 1 inhibitor HSD-016.

  2011cited by this paper
• Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.

  2011cited by this paper
• Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats.

  2011cited by this paper
• Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome.

  2011cited by this paper
• Cortisone-reductase deficiency associated with heterozygous mutations in 11β-hydroxysteroid dehydrogenase type 1

  2011cited by this paper
• Small molecule 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

  2011cited by this paper
• 11β-Hydroxysteroid Dehydrogenase Type 1, But Not Type 2, Deficiency Worsens Acute Inflammation and Experimental Arthritis in Mice

  2011cited by this paper
• Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1).

  2011cited by this paper
• Population Pharmacokinetic/Pharmacodynamic Model of Subcutaneous Adipose 11β‐Hydroxysteroid Dehydrogenase Type 1 (11β‐HSD1) Activity After Oral Administration of AMG 221, a Selective 11β‐HSD1 Inhibitor

  2011cited by this paper
• Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11β-hydroxysteroid dehydrogenase

  2011cited by this paper
• 11-hydroxysteroid dehydrogenases and the brain

  2011cited by this paper
• Genotype at the P554L Variant of the Hexose-6 Phosphate Dehydrogenase Gene Is Associated with Carotid Intima-Medial Thickness

  2011cited by this paper
• Dynamics of insulin secretion and the clinical implications for obesity and diabetes.

  2011cited by this paper
• Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome.

  2011cited by this paper
• Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344).

  2011cited by this paper
• Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice*

  2011cited by this paper
• Effects of an 11β‐hydroxysteroid dehydrogenase type 1 inhibitor, MK‐0916, in patients with type 2 diabetes mellitus and metabolic syndrome

  2011cited by this paper
• The inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by perfluoroalkylated substances.

  2011cited by this paper
• Prenatal Excess Glucocorticoid Exposure and Adult Affective Disorders: A Role for Serotonergic and Catecholamine Pathways

  2011cited by this paper
• Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome.

  2011cited by this paper
• Common Variation at the 11-&bgr; Hydroxysteroid Dehydrogenase Type 1 Gene Is Associated With Left Ventricular Mass

  2011cited by this paper
• Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension.

  2011cited by this paper
• Overexpression of 11β‐hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non‐alcoholic fatty liver disease

  2011cited by this paper
• Regulation of Lipogenesis by Glucocorticoids and Insulin in Human Adipose Tissue

  2011cited by this paper
• Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis

  2010cited by this paper
• Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog.

  2010cited by this paper
• Glucocorticoid-Mediated Inhibition of Angiogenic Changes in Human Endothelial Cells Is Not Caused by Reductions in Cell Proliferation or Migration

  2010cited by this paper
• Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice

  2010cited by this paper
• Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation?

  2010cited by this paper
• 11β-Hydroxysteroid Dehydrogenase Type 1 Expression Is Increased in the Aged Mouse Hippocampus and Parietal Cortex and Causes Memory Impairments

  2010cited by this paper
• Partial Deficiency or Short-Term Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Cognitive Function in Aging Mice

  2010cited by this paper
• Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription.

  2010cited by this paper
• Emodin, a natural product, selectively inhibits 11β‐hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet‐induced obese mice

  2010cited by this paper
• The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors.

  2010cited by this paper
• Discovery of a potent, orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for clinical study: identification of (S)-2-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221).

  2010cited by this paper
• Preliminary report: pharmacologic 11beta-hydroxysteroid dehydrogenase type 1 inhibition increases hepatic fat oxidation in vivo and expression of related genes in rats fed an obesogenic diet.

  2010cited by this paper
• Insulin sensitization of human preadipocytes through glucocorticoid hormone induction of forkhead transcription factors.

  2010cited by this paper
• Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.

  2010cited by this paper
• A novel genetically-obese rat model with elevated 11beta-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue

  2010cited by this paper
• Pseudotumor cerebri after surgical remission of Cushing's disease.

  2010cited by this paper
• Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes.

  2010cited by this paper
• The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

  2010cited by this paper
• Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.

  2010cited by this paper
• Overexpression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients

  2010cited by this paper
• ocal metabolism of glucocorticoids and its role in rat adjuvant arthritis

  2010cited by this paper
• Glucocorticoid‐mediated effects on metabolism are reversed by targeting 11 beta hydroxysteroid dehydrogenase type 1 in human skeletal muscle

  2009cited by this paper
• The amyloidogenic potential and behavioral correlates of stress

  2009cited by this paper
• Tissue-Specific Increases in 11β-Hydroxysteroid Dehydrogenase Type 1 in Normal Weight Postmenopausal Women

  2009cited by this paper
• Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.

  2009cited by this paper
• 11β-Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle

  2009cited by this paper
• 11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents

  2009cited by this paper
• Hepatic 11beta‐HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis

  2009cited by this paper
• Additive action of 11β-HSD1 inhibition and PPAR-γ agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats

  2009cited by this paper
• HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia.

  2009cited by this paper
• Dynamic regulation of mitochondrial function by glucocorticoids

  2009cited by this paper
• Antidiabetic effects of 11β‐HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis

  2009cited by this paper
• Effects of Glucocorticoids on Mood, Memory, and the Hippocampus

  2009cited by this paper
• Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women.

  2009cited by this paper
• Glucocorticoid therapy and risk of bladder cancer

  2009cited by this paper
• Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress

  2009cited by this paper
• Short-term glucocorticoid treatment increases insulin secretion in islets derived from lean mice through multiple pathways and mechanisms.

  2009cited by this paper
• Two asymmetric syntheses of AMG 221, an inhibitor of 11beta-hydroxysteroid dehydrogenase type 1.

  2009cited by this paper
• Discovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes.

  2009cited by this paper
• Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold.

  2009cited by this paper
• Hypothalamic-Pituitary-Adrenal Axis Abnormalities in Response to Deletion of 11β-HSD1 is Strain-Dependent

  2009cited by this paper
• Clinical Implications of Aging Skin

  2009cited by this paper
• Alteration of 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes

  2008cited by this paper
• Effects of altered corticosteroid milieu on rat hippocampal neurochemistry and structure--an in vivo magnetic resonance spectroscopy and imaging study.

  2008cited by this paper
• Looking older: fibroblast collapse and therapeutic implications.

  2008cited by this paper
• Colletoic Acid, a Novel 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor from Colletotrichum gloeosporioides SANK 21404

  2008cited by this paper
• Inhibition of 11βHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice

  2008cited by this paper
• Glucocorticoid receptor variant and risk of dementia and white matter lesions.

  2008cited by this paper
• 11β-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets

  2008cited by this paper
• Modulation of 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11βHSD1 Inhibitor

  2008cited by this paper
• Exploring the pathogenesis of IIH: an inflammatory perspective.

  2008cited by this paper
• Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.

  2008cited by this paper
• 2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice.

  2008cited by this paper
• A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis

  2008cited by this paper
• Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat.

  2008cited by this paper
• Demonstration of Proof of Mechanism and Pharmacokinetics and Pharmacodynamic Relationship with 4′-Cyano-biphenyl-4-sulfonic Acid (6-Amino-pyridin-2-yl)-amide (PF-915275), an Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1, in Cynomolgus Monkeys

  2008cited by this paper
• 11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues.

  2007cited by this paper

• Free fatty acids may regulate the expression of 11β-hydroxysteroid dehydrogenase type 1 in the liver of high-fat diet golden hamsters through the ERS-CHOP-C/EBPα signaling pathway

  2025cites this paper
• Structure-based design, synthesis, and evaluation of tetrahydrotriazolothiazepine derivatives as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

  2025cites this paper
• Beyond the Classical Axis: Metabolic “Pressure” on the Adrenal Gland?

  2025cites this paper
• On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome.

  2025cites this paper
• DSOK‐0011 Potentially Regulates Circadian Misalignment and Affects Gut Microbiota Composition in Activity‐Based Anorexia Model

  2025cites this paper
• Alterations in glucocorticoid homeostasis following sleeve gastrectomy

  2025cites this paper
• Immune Landscape Changes in MASLD and the Effects of 11β‐HSD1 Inhibition Revealed by Single‐Cell Mass Cytometry

  2025cites this paper
• The Role of the Mineralocorticoid Receptor in Skin.

  2025cites this paper
• Prediabetes May Alter HPA Axis Activity and Regulation: A Study on Patients with Prediabetes

  2025cites this paper
• Inter-individual variability, differential tissue abundance, and sub-cellular localization of human aldo-keto reductases (AKRs) and hydroxy-steroid dehydrogenases (HSDs).

  2025cites this paper
• Yinling Qushi Granule as a therapeutic agent for metabolic syndrome: pharmacological, molecular targets, and pharmacokinetic insights

  2025cites this paper
• Mpox Infection and Endocrine Health: Bridging the Knowledge Gap

  2025cites this paper
• A BioID-based approach uncovers the interactome of hexose-6-phosphate dehydrogenase in breast cancer cells and identifies anterior gradient protein 2 as an interacting partner

  2025cites this paper
• Current Understanding of the Pathophysiology of Idiopathic Intracranial Hypertension

  2025cites this paper
• A novel 11β-HSD1 inhibitor ameliorates liver fibrosis by inhibiting the notch signaling pathway and increasing NK cell population

  2025cites this paper
• Age-related increase in the expression of 11β-hydroxysteroid dehydrogenase type 1 in the hippocampus of male rhesus macaques

  2024cites this paper
• Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions

  2024cites this paper
• Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity

  2024cites this paper
• Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines.

  2024cites this paper
• Impaired 11β-HSD1 Activity in a Male Patient With Cushing Disease Resulting in Lack of the Full Cushingoid Phenotype

  2024cites this paper
• Pre-Surgery Cortisol Levels as Biomarker of Evolution after Bariatric Surgery: Weight Loss and Weight Regain

  2024cites this paper
• Cortisol/Cortisone Ratio in Youth with Obesity One Year Following Sleeve Gastrectomy

  2024cites this paper
• Not exclusively the activity, but the sweet spot: a dehydrogenase point mutation synergistically boosts activity, substrate tolerance, thermal stability and yield.

  2024cites this paper
• 11-beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene expression in muscle is linked to reduced skeletal muscle index in sarcopenic patients

  2023cites this paper
• Role of corticosteroids in skin physiology and therapeutic potential of an 11β‐HSD1 inhibitor: A review

  2023cites this paper
• Epigenetic alterations of 11beta-hydroxysteroid dehydrogenase 1 gene in the adipose tissue of patients with primary aldosteronism.

  2023cites this paper
• Comprehensive analysis of the gene expression profile of the male and female BTBR mice with diabetic nephropathy.

  2023cites this paper
• Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms

  2023cites this paper
• The glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 catalyzes the activation of testosterone.

  2023cites this paper
• In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 1 activity.

  2023cites this paper
• Identification of a human blood biomarker of pharmacological 11β‐hydroxysteroid dehydrogenase 1 inhibition

  2023cites this paper
• 11β-Hydroxysteroid Dehydrogenase Type 1 Facilitates Osteoporosis by Turning on Osteoclastogenesis through Hippo Signaling

  2023cites this paper
• An 11-Beta Hydroxysteroid Dehydrogenase Type 1 Inhibitor, JTT-654 Ameliorates Insulin Resistance and Non-obese Type 2 Diabetes.

  2023cites this paper
• Effect of Distinct ECM Microenvironments on the Genome-Wide Chromatin Accessibility and Gene Expression Responses of Hepatic Stellate Cells.

  2023cites this paper
• Inhibition of the glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excess

  2023cites this paper
• Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

  2023cites this paper
• Triterpenoids with multi-skeletons as 11 β -HSD1 inhibitors from Euphorbia sikkimensis.

  2023cites this paper
• Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations

  2023cites this paper
• Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma

  2023cites this paper
• Comparison of alternative splicing (AS) events in adipose tissue of polled dorset versus small tail han sheep.

  2023cites this paper
• Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management

  2023cites this paper
• Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies.

  2023cites this paper
• 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

  2023cites this paper
• Prevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions

  2023cites this paper
• Cortisol excess in chronic kidney disease – A review of changes and impact on mortality

  2023cites this paper
• Narrative Review: Glucocorticoids in Alcoholic Hepatitis—Benefits, Side Effects, and Mechanisms

  2022cites this paper
• Inhibition of 11β‐Hydroxysteroid dehydrogenase‐1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled, phase II study

  2022cites this paper
• Inhibition of 11β-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH

  2022cites this paper
• 11β-HSD1 contributes to age-related metabolic decline in male mice

  2022cites this paper
• Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension

  2022cites this paper
• Tissue-Specific Regulation of 11β Hydroxysteroid Dehydrogenase Type-1 mRNA Expressions in Cushing's Syndrome Mouse Model.

  2022cites this paper
• Regulation of bone mass in endocrine diseases including diabetes.

  2022cites this paper
• Inhibition of 11β-HSD1, a key enzyme in the stress management, improves cognition by RL-118 drug treatment

  2021cites this paper
• The Adrenal Cortex and Its Disorders

  2021cites this paper
• Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice

  2021cites this paper
• Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways

  2021cites this paper
• University of Birmingham Global deletion of 11β-HSD1 prevents muscle wasting associated with glucocorticoid therapy in polyarthritis

  2021cites this paper
• Modulation of 11β-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: the glycyrrhetinic acid-like factor (GALF) hypothesis.

  2021cites this paper
• Global Deletion of 11β-HSD1 Prevents Muscle Wasting Associated with Glucocorticoid Therapy in Polyarthritis

  2021cites this paper
• An open-label phase Ⅰ/Ⅱ a clinical trial of 11β-HSD1 inhibitor for Cushing's syndrome and autonomous cortisol secretion.

  2021cites this paper
• Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure

  2021cites this paper
• Mechanism of glucocorticoid action in immunology—Basic concepts

  2021cites this paper
• 11β-hydroxysteroid dehydrogenases: a growing multi-tasking family.

  2021cites this paper
• The ratio of ursodeoxycholyltaurine to 7‐oxolithocholyltaurine serves as a biomarker of decreased 11β‐hydroxysteroid dehydrogenase 1 activity in mouse

  2021cites this paper
• Variation in glucocorticoid sensitivity and the relation with obesity

  2021cites this paper
• The mineralocorticoid receptor in skin disease

  2021cites this paper
• New Targets for Drug Therapy in Type 2 Diabetes Mellitus

  2021cites this paper
• An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia

  2020cites this paper
• 11β-hydroxysteroid dehydrogenase type 1 inhibitor use in human disease- a systematic review and narrative synthesis.

  2020cites this paper
• Glucocorticoid resistance syndrome

  2020cites this paper
• Emerging role of GIP and related gut hormones in fertility and PCOS.

  2020cites this paper
• Investigating glucocorticoids as mediators of increased bone marrow adiposity and bone loss

  2020influential citation
• Thyroid Hormones, Glucocorticoids, Insulin, and Bone.

  2020cites this paper
• Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment

  2020cites this paper
• Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes

  2020cites this paper
• Causes, consequences, and treatment of metabolically unhealthy fat distribution.

  2020cites this paper
• The science of steroids.

  2019cites this paper
• Steroid secretion in healthy aging.

  2019cites this paper
• Increased central adiposity and decreased subcutaneous adipose tissue 11β‐hydroxysteroid dehydrogenase type 1 are associated with deterioration in glucose tolerance—A longitudinal cohort study

  2019cites this paper
• Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor‐developing stage

  2019cites this paper
• Glucocorticoid Metabolism and Activation

  2019cites this paper
• Steroid metabolomic signature of liver disease in nonsyndromic childhood obesity

  2019cites this paper
• Rooibos (Aspalathus linearis) and Honeybush (Cyclopia spp.): From Bush Teas to Potential Therapy for Cardiovascular Disease

  2019cites this paper
• Perturbed ovarian and uterine glucocorticoid receptor signaling accompanies the balanced regulation of mitochondrial function and NFκB-mediated inflammation under conditions of hyperandrogenism and insulin resistance.

  2019cites this paper
• Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review

  2019cites this paper
• The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat.

  2019cites this paper
• 11β-HSD1 Inhibition Rescues SAMP8 Cognitive Impairment Induced by Metabolic Stress

  2019cites this paper
• Non-alcoholic fatty liver disease in lean individuals

  2019cites this paper
• Exploring the Interface between Inflammatory and Therapeutic Glucocorticoid Induced Bone and Muscle Loss

  2019cites this paper
• Optimization of cyclic sulfamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors for the potential treatment of ischemic brain injury.

  2019cites this paper
• Diurnal Patterns for Cortisol, Cortisone and Agouti-Related Protein in Human Cerebrospinal Fluid and Blood.

  2019cites this paper
• Chemoinformatics in Natural Product Research

  2018cites this paper
• Role of 11β-HSD type 1 in abnormal HPA axis activity during immune-mediated arthritis

  2018cites this paper
• Gut microbiota, hypertension and chronic kidney disease: Recent advances.

  2018cites this paper
• Medicinal plants in Asia for metabolic syndrome

  2018cites this paper
• Identification of a fish short-chain dehydrogenase/reductase associated with bone metabolism.

  2018cites this paper
• Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy.

  2018cites this paper
• Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1).

  2018cites this paper
• Clinical outcome in anti-neutrophil cytoplasmic antibody–associated vasculitis and gene variants of 11&bgr;-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptor

  2018cites this paper
• Hydroxysteroid 11-Beta Dehydrogenase 1 Overexpression with Copy-Number Gain and Missense Mutations in Primary Gastrointestinal Stromal Tumors

  2018cites this paper